TrianglePUBLICATIONS · 33823073
Outcome of patients with chronic myeloid leukemia in lymphoid blastic phase and Philadelphia chromosome-positive acute lymphoblastic leukemia treated with hyper-CVAD and dasatinib.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- Cancer
- Publication date
- 2021 Aug 1
- First author
- Morita K
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
Authors and identifiers
- name
- Morita K
- type
- Author
- name
- Kantarjian HM
- type
- Author
- name
- Sasaki K
- type
- Author
- name
- Issa GC
- type
- Author
- name
- Jain N
- type
- Author
- name
- Konopleva M
- type
- Author
- name
- Short NJ
- type
- Author
- name
- Takahashi K
- type
- Author
- name
- DiNardo CD
- type
- Author
- name
- Kadia TM
- type
- Author
- name
- Garcia-Manero G
- type
- Author
- name
- Daver N
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- Morita K
- type
- Author
- name
- Kantarjian HM
- type
- Author
- name
- Sasaki K
- type
- Author
- name
- Issa GC
- type
- Author
- name
- Jain N
- type
- Author
- name
- Konopleva M
- type
- Author
- name
- Short NJ
- type
- Author
- name
- Takahashi K
- type
- Author
- name
- DiNardo CD
- type
- Author
- name
- Kadia TM
- type
- Author
- name
- Garcia-Manero G
- type
- Author
- name
- Daver N
- type
- Author
- bibliography ids
- nci-bib-a4a82977557e09eaa24ae9d2
- book metadata
- content sha256
- a0da651cf7caec19069e2953f427eed3f8853ac86107580fc089d32b3313e4c3
- document type
- citation
- dois
- 10.1002/cncr.33539
- electronic publication date
- display
- 2021 Apr 6
- precision
- day
- year
- 2021
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:33823073
- immutable id
- pubmed:33823073@a0da651cf7caec19069e2953f427eed3f8853ac86107580fc089d32b3313e4c3
- journal
- abbreviation
- Cancer
- issn electronic
- 1097-0142
- issn print
- 0008-543X
- issue
- 15
- name
- Cancer
- nlm unique id
- 0374236
- pages
- 2641-2647
- volume
- 127
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- outcomes validated
- false
- pmid
- 33823073
- provenance
- batch id
- 79f1021053e858d13ff3
- provider
- NCBI PubMed ESummary
- record sha256
- 809e5efa4a6181fcc554c5ad8ab7d5c224860d6db8187644c93910d09ffb106f
- response sha256
- 671d3d2962f73c698a1cb338d73222e2cc6cfdf61569f91b42612d5b59822e05
- retrieved at
- 2026-09-09T23:47:59.098265+00:00
- publication date
- display
- 2021 Aug 1
- precision
- day
- year
- 2021
- publication types
- Journal Article
- Research Support, N.I.H., Extramural
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- title
- Outcome of patients with chronic myeloid leukemia in lymphoid blastic phase and Philadelphia chromosome-positive acute lymphoblastic leukemia treated with hyper-CVAD and dasatinib.
Preserved source evidence · Not medical advice